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INTRODUCTION
Drugs which act as metabolic inhibitors are of increasing importance for bio-
chemical-pharmacological research. This is comparable to the development of
radionuclids some years ago, but it is necessary in this case that they act spe-
cifically. From experiments with such compounds information can be obtained on
the number and kind of metabolic pathways as well as on the mechanisms of struc-
tural relations at the molecular level. In other words, the value of these inhibitors
for therapeutic research has two aspects: (1 ) they are per se potential therapeutics
simply by their characteristic inhibitory effect, and (2) the elucidation of metabolic
disturbances leads to an understanding of the pathogenesis and sometimes to the
etiology of a given disease. This could be the basis for further therapeutic
experiments.
To find a useful therapy for human malignant melanoma we studied the effects
of proflavine and ethidiumbromide on the hamster melanoma A Mel 3 of Fortner
as a model.
MATERIALS AND METHODS
All metheds used here were described in detail previously (1-3). Radioactive-
labeled chemicals were obtained from Radiochemical Centre, Amersham, England,
all other chemicals from Serva, Heidelberg, Germany. Proflavine was purchased
from Fluka AG, Buchs/SG, Switzerland.
The hamster melanoma A Mel 3 of Fortner was propagated serially by sc inocu-
lation of 1.5-3.0 X 10 cells into female golden Syrian hamsters weighing 80-100
g.
Subcellular particles were obtained after tumor homogenization in 0.25 M su-
crose containing 10 mM Tris/HCl and 2 mM EDTA at pH 8.3 followed by differ-
ential centrifugation. To obtain the "purified" virus fraction the microsomal frac-
tion was layered on a discontinuous sucrose gradient (50%/35%/20%) and
centrifuged to equilibrium.
Incubation mixture for RNA-directed DNA synthesis contained in micromoles: 8
of Tris/HCl (pH 8.3), 1 of MgCl.., 6 of KCl, 3 of dithiothreitol, 0.2 each of the
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unlabeled deoxyribonucleoside triphosphates (dATP, dGTP, dCTP), and 0.01 of
dTTP. 25 uliters of [3H]dTTP (2 mCi/ml) were added and when indicated Y/2
O.D. unit poly dT:rA. Particle protein was not more then 150 jug, suspended in
10 nM Tris/HCl (pH 8.3), 150 mM NaCl, and 2 mM EDTA. The final concentra-
tion of Nonidet P 40 was 0.08% in the final volume of 125 M.liters. After 30 min
at 370C the reactions were stopped by addition of 10% perchloric acid containing
50 mM sodium pyrophosphate, the precipitates washed in ethanol and counted,
using PBD scintillator.
For nucleic acids extraction in a volume of 1.0 ml the samples were incubated
with 1 % pronase in Tris/HCl (pH 8.3) and thereafter extracted three times by
phenol/m-cresol/8-hydroxyquinoline/water 500:70:0.5:55 (w/w) and 0.5% final
concentration of sodium dodecylsulfate. The aqueous phase was washed four times
with ether and the nucleic acids were precipitated by addition of 2 vol of absolute
ethanol, recrystallized, and lyophilized. The dried nucleic acids were redissolved
in 10 mM Tris/HCl (pH 8.0), 20 mM NaCl, and 2 mM EDTA and fur-
ther characterized by isopycnic centrifugation in a linear gradient formed from 15
to 30% glycerol. Concentrations of nucleic acids were calculated from their ab-
sorbance ratio at 260 and 280 nm.
The subcellular fractions were examined by electron microscopy after fixation
in 1% OSO4 in 0.1 M cacodylate buffer (pH 7.2) and postfixation in 0.5% aqueous
uranyl acetate, for 1 hr each, dehydration in ethanol and embedding in Epon 812.
Thin sections were cut on a LKB ultrotome III with a diamond knife, mounted
on copper grids covered with collodium and carbon films, stained with magnesium
uranyl acetate and lead citrate and examined in a Siemens Elmiskop IA or 101
operated at 80 kV with a 50 ,tm objective aperture. The in vivo experiments are
described in the text.
RESULTS
1. Survival Time
Tumor-bearing animals receiving 2.4 mg proflavine dissolved in drinking water
each day (from the time of sc inoculation with tumor cells until they died) survive
about twice as long as untreated ones (Table 1). Depending on dosage and time
schedule, the survival time can be enlarged up to 10 wk after sc injection of the
drug.
2. RNA-Directed DNA Synthesis
Subcellular particles of the hamster melanoma exhibit an RNA-directed DNA
polymerase activity (3, 4). The isolated RNA-DNA hybrid is indeed strong evi-
TABLE 1
EFFECT OF PROFLAVINE ON THE SURVIVAL TIME (A MEL 3)a
Survival time
Days after
tumor inoculation Factor
Control (untreated) -14
Proflavine treated 27 X1 .9
a All animals were inoculated sc by 1.0-2.6 X 106 melanoma cells. Proflavine was given orally in a
dosage of 2.4 mg per day and animal.
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dence that this enzymic activity is dependent on high molecular weight RNA (4).
The extent to which radioactivity was incorporated into polynucleotide, expressed
as specific radioactivity, correlated with the source of the enzyme. For example,
the microsomal fraction gave unsatisfactory results because of high levels of non
virus-associated RNase and DNase activities. Virus particles are rare in this frac-
tion, indicated by electron microscopical controls. Therefore we used a fraction
FIG. 1. Electron micrograph of the "purified" virus fraction as obtained from density
gradient centrifugation in sucrose (50/35/20%). Virus particles are recognizable by the
electron-dense nucleoid. X100,000.
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TABLE 2
EFFECT OF PROFLAVINE ON THE RNA-DIIRECTED DNA SYNTIIESIS (A MEL 3)a
cp1)111/ mg
pi)Oteini Iinhibition
Stanidard assay (f+poly dT:rA) 49250
+Proflavine (20 jig/ml) 9950 30.0
+Proflavine (40 jAg/mlI) 1380 68.0
+HProflavine (80 jig/mlll) 570) 86.5
+Proflavine (100 jig/ili) 158 96.2
a For details sec Alaterial anid Mtethods.
TABLE 3
FEFFECT OF ETHIDIUJMBIZOMIDE ON THE RNA-DIHIECTED D)NA SY-NTIIHESIS (A Mi.:L 3I),,
C't)Ill/Inlg SC/
protein Inh11ibitioii
Stanidard assay (witliout poly dT: rA) 650 --
+Ethidiuinbromide (20 jig/ml) 550 15.0
+Ethidiuimbromide (40 jig/mlI) 39)4 50 0
+Ethidiuinbromide (80 jig/iril) 279 58.0
Stanidard assay (-+fpoly dT: rA) 4950
+Ethidiumhromide (20 ug/inil) 9150( 50 .0
+Ethidiumbromide (40 jig/mil) 1 970 70 .0
+-Etiiditimbromide (80 jig/ml) 49-5 90..0
For details see Material aind AMethods.
enriched with viruses, which could be obtained after an additional discontinuous
density-gradient centrifugation step (4). The electron micrograph of this fraction
(Fig. 1 ) shows an appreciable number of virus particles besides numerous reaggre-
gated membranes.
Another important consideration is the requirement of the nonionic detergent
Nonidet P 40. The optimal assay concentration is about 0.1%.
Small amounts of proflavine (20 ,lg/ml) added to the incubation mixture inhibit
remarkably the RNA-directed DNA synthesis. Depending on dosage, the reaction
is almost completely inhibited (Table 2). Ethidiumbromide has the same, perhaps
a little stronger, effect (Table 3). It is of interest that the inhibition is more evident
after stimulating the enzyme assay by poly dT:rA (Table 3).
3. [3H]-Uridine Incorporation into RNA
[3H]-uridine (0.2 mCi/animal) administered sc is, after 2 hr, incorporated into
RNA species, which could be isolated from the mitochondrial and microsomal frac-
tion and also from the virus-enriched fraction. Density-gradient centrifugation of
the total RNA from all these fractions shows the presence of a high molecular
weight RNA (3). When ethidiumbromide in a dosage of 40 mg/kg body weight
is injected sc the incorporation of the radioactive labeled nucleoside into RNA
is markedly reduced. As shown in Pg. 2, the most markedly reduced RNA species
are the 4 S and 70 S RNA.
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FIG. 2. Sedimentation profile and distribution of radioactivity of [3Hjuridine'labeled RNA
from microsomes of melanoma. Closed circles: OD260. Open circles: specific radioactivity
in the absence of ethidiumbromide. Open triangles: specific radioactivity in the presence
of ethidiumbromide. Ethidiumbromide was injected sc 2 hr prior to ['H]uridine in a dosage
of 40 mg/kg body weight.
DISCUSSION
Using the acridine dye proflavine and the phenanthridine dye ethidiumbromide
special features of the metabolism of the hamster melanoma A Mel 3 were analysed.
Biochemical experiments were undertaken to clarify the twice-as-long survival time
of proflavine-treated tumor-bearing animals in comparison to untreated ones.
As previously described, the in vivo incorporation of [3H]phenylalanine into
mitochondrial and microsomal proteins of the melanoma is reduced by about 90%
when proflavine is administered 60 min prior to phenylalanine (5). We had also
found a tumor-characteristic and proflavine-sensitive protein synthesis (2). In prin-
ciple these findings could be explained by the action of degradative enzymes in
the melanoma, which become active by accidental derepression of some genes, but
we have no support for it at the moments.
However, it is known that viruses can be detected in animal melanomas (6-8).
Therefore, we checked the sensitivity of the tumor tissue against proflavine and
ethidiumbromide. The two main characteristics of oncogenic RNA viruses are a
RNA-directed DNA polymerase, the so-called reverse transcriptase (9), and a sin-
gle-stranded high molecular weight or 70 S RNA (10). In addition to the previ-
ously described properties of this RNA-directed DNA synthesis (4), it is greatly
of interest that this reaction could be strongly inhibited in vivo by proflavine and
ethidiumbromide. These drugs also inhibited the in vivo synthesis of both high
molecular weight and 4S RNA.
All these findings do not agree with the hitherto known proflavine and ethidium-
bromide action on the molecular level. These two drugs are well known as inter-
calating agents for double-stranded circular DNA (11-15). More recently, Finkel-
stein and Weinstein and Weinstein and Finkelstein (16, 17) were able to show
that tRNA species could also interact with proflavine.
From these results we may suggest the following more detailed mode of action
of proflavine and ethidiumbromide at the molecular level in virus-transformed cells
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FIG. 3. The supposed action of proflavine and ethidiumbromide (both indicated by EB)
at the molecular level in virus-transformed cells. For details see discussion.
(Fig. 3). First, the drugs act preferentially with double-stranded circular DNA
(in normal cells mitochondrial DNA represents such a species). As found previ-
ously, the synthesis of mitochondrial DNA in the hamster melanoma is very
strongly inhibited (1). Not clear at present is whether or not the drugs intercalate
with such DNA sequences which contain viral sequences, called oncogens, indi-
cated here as VS-DNA. Second, the dyes can interact with tRNA species. In this
way regulatory functions (16) and the protein synthesis at the ribosomal level are
blocked. It is supposed that most of 4 S RNA contains virus-coded species. Third,
the 70 S RNA interacts with the dyes. Compared to other mammalian RNA species
this implicates structural and base-sequence abnormalities of the 70 S RNA. Prob-
ably this single-stranded, high molecular weight RNA is at least partially double-
stranded. Finally, the RNA-directed DNA polymerase probably interacts at least
partially with the inhibitors, so that this enzyme may also be structurally peculiar.
In summarizing the presented results, it should be emphasized that the viral etiol-
ogy of the hamster melanoma becomes clearer and the drugs used are potentially
therapeutic for this tumor because of their specific action. For use in man they
are at present too toxic, though slight change in the molecule may provide a useful
drug. Preliminary results suggest a similar inhibitory effect on the RNA-directed
DNA synthesis of these drugs in human melanoma (17). This is consistent with
previously described observations of virus particles present in lymph node metasta-
ses of human melanomas detected by electron microscopy (18).
SUMMARY
Using the hamster melanoma A Mel 3 of Fortner as a model for the human
malignant melanoma the effects of two dyes, proflavine and ethidiumbromide, were
studied. Both drugs given in vivo prolong the survival time and inhibit the synthesis
of 4 S and 70 S RNA. They also act as very strong inhibitors of the RNA-directed
DNA synthesis in vitro. A specific action of these drugs on the oncoma-virus trans-
formed melanoma cells is assumed. Preliminary results parallel these findings for
the human melanoma also.
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